Advocacy

 

Since 1989, AIRI has been involved in monitoring federal policy and funding issues affecting biomedical research in Washington, D.C. The AIRI Washington Office has extensive experience in public policy issues related to biomedical and behavioral research and health care.

 
The Washington Office works closely with the AIRI Government Affairs Committee (GAC) to keep members abreast of new developments in Congress and across the federal government affecting independent research institutes; to educate policymakers about the contributions of independent research institutions to health care and economic development in this country; and to alert AIRI members to actions needed to influence their legislators in Washington. The AIRI Washington Office works to develop and maintain connections with lawmakers and various coalitions to promote common interests.

Every year, the AIRI GAC and the AIRI Washington Office establish Congressional and Executive Branch priorities. The AIRI Washington Office advocates for these priorities throughout the year through meetings with Members of Congress and staff, Executive Branch agencies, Action Alerts to the AIRI membership, and collaborative efforts with patient advocacy groups and the research and scientific communities. Below are documents illustrating some of AIRI's recent activities. For advocacy-related inquiries, please contact Libby O'Hare at the AIRI Washington Office.
 
  1. AIRI FY 2019 House Written Testimony
  2. AIRI FY 2019 Senate Written Testimony
  3. AIRI Letter to OMB Director Mick Mulvaney and HHS Secretary Tom Price Regarding the Proposed 10 Percent Cap on F&A Costs on NIH Awards 
  4. AIRI Letter Submitted to the House Science Committee, Research & Technology Subcommittee Regarding F&A Costs
  5. Testimony Submitted to the Senate Labor-HHS-ED Subcommittee Regarding FY 2018 NIH Funding
  6. AIRI and COGR Letter to OIRA Administrator Howard Shelanski on Micropurchase Threshold
  7. Association Letter to OMB Opposing Micropurchase Threshold in Uniform Guidance
  8. AIRI Comment Letter on Human Subjects Proposed Rule
  9. AIRI Coalitions
Advocacy

Click here for information on joining AIRI!